Results 191 to 200 of about 488,996 (261)

Correction: Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. [PDF]

Front Immunol
Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, Hall E, Herrera M, Parikh P, Guevara-Coto J, Triche TJ, Scott P, Hekmati S, Maglinte D, Chang X, Mora-Rodríguez RA, Mora J.   +16 more
europepmc   +1 more source

Evaluation of Dried Plasma Spot‐Based Quantification of Glial Fibrillary Acidic Protein as a Disease‐Associated Biomarker in Neuromyelitis Optica Spectrum Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the diagnostic accuracy of glial fibrillary acidic protein (GFAP) measured in dried plasma spots versus conventional plasma‐ and serum‐GFAP testing for assessment of disease severity in aquaporin‐4 immunoglobulin G–positive neuromyelitis optica spectrum disorder (AQP4‐IgG+ NMOSD).
Felix Wohlrab, Evelyn Alvarez, Roua Hamdi, Bingqing Zhang, Hayeun Ji, Niyati Jhaveri, Patrick Schindler, Pedro Sanchez, Pia S. Sperber, Tanja Schmitz‐Hübsch, Frederike C. Oertel, Nisa Vorasoot, Najib Kissani, Falko Böhringer, Jens Kuhle, Anne‐Katrin Pröbstel, Xiao‐Jun Ma, Péter Körtvelyessy, Patrick Waters, Friedemann Paul   +19 more
wiley   +1 more source

Diagnosis, treatment, and biosafety protection of imported highly pathogenic cutaneous fungal infection: a case-based study of cutaneous coccidioidomycosis. [PDF]

Front Public Health
Weng Y, Liu Z, Xia X.
europepmc   +1 more source

Sitagliptin, Metformin and Glimepiride Fixed-Dose Combination Compared to Co-Administration of Metformin and High-Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double-Blind, Double-Dummy, Phase 3 Clinical Study. [PDF]

Diabetes Obes Metab
Sahay R, Gowda A, Singh MK, Rao AG, Duraisamy R, Gangwani D, Shukla J, Agarwal V, Patil SS, C A, K N SB, Palawat A, Gofne SK, Sahoo AK, Rai PK, Shaikh R, Saha S, Patil D, Ghadge P, Patel P, Lakhwani L, Mehta S, Joglekar S.   +22 more
europepmc   +1 more source

Patient Data and refineR for Efficient Monitoring and Verifying Laboratory Reference Intervals: A Practical Approach. [PDF]

Ann Lab Med
Díaz-Garzón Marco J, Prieto Arribas D, Moreno-Parro I, Sufrate-Vergara B, Mora Corcovado R, Buño Soto A, Fernández-Calle P.   +6 more
europepmc   +1 more source

Antimicrobial susceptibility trends of WHO critical Gram-negative pathogens in Fijian Hospitals, 2016-2021. [PDF]

JAC Antimicrob Resist
Baleivanualala SC, Soqo V, Smita S, Sharma S, Devi SV, Delaitoga L, Maharaj K, Autar S, Racolo T, Vera N, Naivalu TK, Wilson D, Crump JA, Ussher JE.   +13 more
europepmc   +1 more source

Notes from the Field: Initial Public Health Response to a Measles Outbreak in a Close-Knit West Texas Community - January-February 2025. [PDF]

MMWR Morb Mortal Wkly Rep
Crisp CA, Milton S, Lutz CS, Northcott K, McClaran K, Hernandez C, Almas S, Holbrooks Z, Wells K, Sajewski E, Texas 2025 Measles Outbreak Response Team, CDC Epi-Aid Measles Response Team, Morrison A, Schroeder C, Nolen M, Gonzales J, Martinez D, Rai S, Shetty V, Shuford JA.   +19 more
europepmc   +1 more source

Yeast identification, antifungal susceptibility testing, and <i>Candida auris</i> screening practices at acute care hospitals and long-term acute care hospitals, United States. [PDF]

J Clin Microbiol
Gold JAW, Benedict K, Haass KA, Kaur H, Muthe P, Bouwkamp BA, Lyman M, Toda M, Rivers T, Lockhart SR.   +9 more
europepmc   +1 more source